Guobang Pharma Ltd. (SHSE: 605507)
Health Care · Pharmaceuticals · CN
CN¥17.31
-4.31% today · +3.3% 1Y
Guobang Pharma Ltd. (SHSE: 605507) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.00B and employs 4,251 people.
Over the last twelve months the share price has gained 3.3%, trading between 14.34 and 21.41.
Tweenvest scores Guobang Pharma Ltd. across four factors: quality 80/100, value 37/100, growth 54/100, dividend 72/100. Its strongest factor is quality.
605507 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.00B
- Revenue (TTM)
- $902.06M
- P/E
- 18.90
- EPS
- 0.92
- Dividend yield
- 2.48%
- Beta (5Y)
- 0.15
- 52-week high
- CN¥21.41
- 52-week low
- CN¥14.34
- Avg volume (3M)
- —
- Shares outstanding
- 772.00M
- Employees
- 4,251
- Next earnings
- —
About Guobang Pharma Ltd.
Guobang Pharma Ltd., a Chinese company, specializes in the research, development, manufacturing, and distribution of pharmaceutical products for both human and veterinary use within China. For human healthcare, their offerings encompass active pharmaceutical ingredients (APIs), intermediate compounds related to these APIs, and finished dosage forms. In the animal health sector, they provide veterinary APIs, various additives, and prepared formulations. The company was founded in 1996 and has its headquarters situated in Xinchang, China.
- ISIN
- CNE100004NS2
- Founded
- 1996
- Listed since
- Aug 2, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zhejiang Hisun Pharmaceutical Co., Ltd.SHSE: 600267 | $2.06B | CN¥11.94 | +1.62% |
| Shilpa Medicare LimitedBSE: 530549 | $2.06B | Rs1,020.35 | -4.07% |
| Trulieve Cannabis Corp.NYSE: TRLV | $2.05B | $10.67 | +2.89% |
| Fujian Cosunter Pharmaceutical Co., Ltd.SZSE: 300436 | $2.04B | CN¥81.47 | -2.64% |
| PT Kalbe Farma Tbk.IDX: KLBF | $1.99B | Rp785.00 | +8.28% |
| Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.SHSE: 603707 | $1.97B | CN¥8.18 | -0.12% |
| Shenzhen Hepalink Pharmaceutical Group Co., Ltd.SZSE: 002399 | $1.95B | CN¥9.89 | +0.41% |
| Caplin Point Laboratories LimitedBSE: 524742 | $1.93B | Rs2,459.55 | -6.56% |
Figures last refreshed Oct 11, 2026.